Trial of Zolpidem for Sleep in Children With Autism

Trial ID or NCT#

NCT05540574

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to examine the effect of zolpidem on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Zolpidem is a nonbenzodiazepine GABAa receptor agonist drug that acts as a hypnotic. To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of zolpidem on sleep physiology as assessed by polysomnography (PSG), actigraphy, circadian rhythm, and clinical measures.

Official Title

Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism

Eligibility Criteria

Ages Eligible for Study: 8 Years to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Antonio Hardan, M.D.
Antonio Hardan, M.D.
Psychiatrist
Professor of Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

Contact

Joe McGrath
650-736-1235